ArticleCureus2026
Tachycardia As Therapy: Control of an Electrical Storm Through Mechanism-Directed Treatment After Refractory Ventricular Arrhythmias.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrical storm (ES) is a life-threatening clinical syndrome defined by recurrent episodes of ventricular tachycardia (VT) or ventricular fibrillation (VF) within a short time frame. Although contemporary management relies on guideline-directed therapies, including antiarrhythmic drugs, deep sedation, sympathetic modulation, and catheter ablation in selected refractory cases, some patients remain unstable and require individualized treatment guided by the suspected electrophysiological substrate. We report the case of a 44-year-old previously healthy woman who presented with out-of-hospital cardiac arrest due to VF. Following successful resuscitation, she developed recurrent polymorphic VT apparently initiated by short-coupled premature ventricular complexes (PVCs). Despite implementation of several conventional and guideline-supported strategies for ES, ventricular arrhythmias continued to recur. The clinical pattern and electrocardiographic/telemetry recordings were considered compatible with a short-coupled ectopy-triggered mechanism, raising suspicion for a Purkinje-mediated substrate. Based on this hypothesis, a therapeutic strategy aimed at increasing the basal heart rate was adopted using continuous isoproterenol infusion. Following isoproterenol titration to achieve sinus tachycardia of approximately 120 beats per minute, no further VT was documented. Quinidine therapy was subsequently introduced, allowing withdrawal of isoproterenol with sustained arrhythmia suppression. This case illustrates how careful interpretation of arrhythmia patterns may guide therapeutic decisions in refractory ES and highlights the potential role of heart rate acceleration in selected patients with suspected short-coupled PVC-triggered ventricular arrhythmias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.